Literature DB >> 9130261

A role for complement in phagocytosis of myelin.

B A DeJong1, M E Smith.   

Abstract

The mechanisms for phagocytosis of myelin in cell-mediated demyelinating diseases have not been clarified. We have previously shown with cultured phagocytic cells that myelin opsonized with antiserum to myelin constituents is phagocytized in much higher amounts than untreated myelin, indicating that Fc receptors may be involved in the demyelinating process. Using various treatments of antisera, such as heating to destroy complement, and purification of IgG, we show here that complement is a necessary factor for maximal myelin phagocytosis by cultured macrophages. If myelin is sonicated to decrease its particle size, however, complement is not an active factor. Cultured microglia, on the other hand, required complement for maximal phagocytosis of both unsonicated and sonicated myelin. Addition of serum complement greatly increased phagocytosis of untreated CNS and PNS myelin, both unsonicated and sonicated, by macrophages and microglia. From these results it appears that the most important effect of complement is to fragment the myelin, making it more easily phagocytized. Prefragmentation of myelin by sonication can substitute for complement. Complement receptors may, in addition, be important for maximal myelin phagocytosis by microglia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130261     DOI: 10.1023/a:1027372129989

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents.

Authors:  K Mosley; M L Cuzner
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

2.  The initial structural lesion in serum-induced demyelination in vitro.

Authors:  M B Bornstein; C S Raines
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

3.  Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis.

Authors:  L G Epstein; J W Prineas; C S Raine
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

4.  Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis.

Authors:  C Linington; H Lassmann; B P Morgan; D A Compston
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid.

Authors:  H Link; S Baig; O Olsson; Y P Jiang; B Höjeberg; T Olsson
Journal:  J Neuroimmunol       Date:  1990-08       Impact factor: 3.478

6.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement.

Authors:  H Lassmann; H Stemberger; K Kitz; H M Wisniewski
Journal:  J Neurol Sci       Date:  1983-04       Impact factor: 3.181

8.  Phagocytosis of myelin by microglia in vitro.

Authors:  M E Smith
Journal:  J Neurosci Res       Date:  1993-08-01       Impact factor: 4.164

9.  TNF-alpha suppresses CR3-mediated myelin removal by macrophages.

Authors:  W Brück; Y Brück; R L Friede
Journal:  J Neuroimmunol       Date:  1992-05       Impact factor: 3.478

10.  Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.

Authors:  K A Brokstad; M Page; H Nyland; L R Haaheim
Journal:  Acta Neurol Scand       Date:  1994-06       Impact factor: 3.209

View more
  6 in total

Review 1.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 2.  Phagocytosis of myelin in demyelinative disease: a review.

Authors:  M E Smith
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 3.  Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 4.  The double-edged sword of autoimmunity: lessons from multiple sclerosis.

Authors:  Anne Lise K Hestvik
Journal:  Toxins (Basel)       Date:  2010-04-22       Impact factor: 4.546

Review 5.  Phagocytosis in the Brain: Homeostasis and Disease.

Authors:  Dylan A Galloway; Alexandra E M Phillips; David R J Owen; Craig S Moore
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

6.  Deficiency of Complement Component C1Q Prevents Cerebrovascular Damage and White Matter Loss in a Mouse Model of Chronic Obesity.

Authors:  Leah C Graham; Heidi E Kocalis; Ileana Soto; Gareth R Howell
Journal:  eNeuro       Date:  2020-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.